trending Market Intelligence /marketintelligence/en/news-insights/trending/S60wHov8uLkfIQmbdMt3QA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Marina Biotech adds board member

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Marina Biotech adds board member

Philippe Calais was elected to the board of Marina Biotech Inc., which he will join effective Jan. 1, 2017.

Calais is CEO of Isarna Therapeutics GmbH.

The company also said that Joseph Ramelli will transition from interim CEO to permanent chief executive. Ramelli will step down from the board to keep the board size at five members.